19 May 2013
Keywords: medarex/medimmune, begin, dosing, ph, medi-545, trial, medarex
Article | 24 April 2006
Medarex says that its partner, fellow US drugmaker MedImmune, has begun dosing patients in a Phase I clinical trial of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 May 2006
8 May 2006
17 May 2013
© 2013 thepharmaletter.com